Yazar "Veral, A. ," için listeleme
-
Which tyrosine kinase inhibitor must we apply before? A case report of crizotinib-resistant patient with concomitant EGFR and EML4-ALK gene mutations
Çokmert, S.; Veral, A. ,; Akyürek, N.; Keçeci, S.D.; Sivrikoz, O.; Yılma, E.; Tanrıverdi, Özgür; Coşkun, U. (University of the West Indies, 2021)The concomitant epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) translocations in lung adenocancers are very rare scenarios. Until now, 42 cases described in the literature have all ...
